Circular packaging – Delivery of pharmaceutical vials in circular packaging.

The uniqueness of SCHOTT Pharma’s circular tray initiative lies in a systemic, pharma‑compliant methodology that re‑engineers how intermediate packaging is designed, used, recovered, and remanufactured within a regulated pharmaceutical environment.At its core is a closed‑loop tray‑to‑tray recycling system that preserves full material control across the entire lifecycle. Unlike conventional recycling, which relies on mixed and uncontrolled waste streams, this system establishes a dedicated reverse‑logistics flow: used polypropylene trays are collected directly at pharmaceutical manufacturing sites, kept separate from other waste, compacted, and returned to the tray manufacturer in a clean and controlled manner. This loop enables traceability, mitigates contamination risks, and meets stringent pharma quality requirements.Pharma‑specific risk assessment and material validation are embedded as core design principles. Comprehensive testing confirmed that recycled polypropylene from the closed loop shows equivalent mechanical performance, chemical stability, and volatile organic compound (VOC) behavior compared to virgin material, ensuring patient safety. Trays are remanufactured with up to 70% recycled content and seamlessly reintegrated into existing vial packaging and filling operations without changes to validated processes.What truly differentiates this approach is its industrial‑scale applicability. The system is about to progress from ton‑scale pilots to routine operations and commercial supply, supported by independent, ISO‑compliant life‑cycle assessment demonstrating up to 50% lower greenhouse gas emissions per tray.By combining circular design, controlled reverse logistics, rigorous pharma validation, and third‑party environmental verification, SCHOTT Pharma and its partners Takeda and Corplex have created a first‑of‑its‑kind circular packaging solution tailored to the pharmaceutical industry.